Sign in

Private company

Genetron Holdings Ltd

Medical laboratories services company in the Cayman Islands1

In its 2023 annual report (Form 20-F) the company says: “Genetron is a holding company and does not directly own any substantive business operations in the PRC. We currently focus our business operations within the PRC primarily through Genetron Health and its subsidiaries. Our corporate headquarters is located at 1-2/F, Building 11, Zone 1, No.8 Life Science Parkway Changping District, Beijing, People’s Republic of China.”13

Last updated Oct 21, 2026.

Overview

$94.3MRevenue, fiscal 20222
-$117.5MNet income, fiscal 20222
  • IndustryServices-Medical Laboratories1
  • HeadquartersBeijing, China1
  • Incorporated inCayman Islands3
  • Business address1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District, Beijing, F4 1022063
  • Filer categoryAccelerated filer3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

43.3%Gross margin2
-107.9%Operating margin2
-124.6%Net margin2
13.0%Revenue growth, 20222
-147.8%Return on equity2
0.01×Debt to equity2
-$77.2MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue48¢$53.5M
  • Research and development38¢$42.1M
  • Interest14¢$16.2M

Out of $94.3M in revenue.2 The company lost money this year.

Financial statements

Revenue452$94.3M in 2022+45% since 2020
0$25.0M$50.0M$75.0M$100.0M2020: $65.1M$65.1M20202021: $83.5M$83.5M2021+28%2022: $94.3M$94.3M2022+13%
Gross profit452$40.8M in 2022+2% since 2020
0$20.0M$40.0M$60.0M2020: $39.9M$39.9M20202021: $53.0M$53.0M2021+33%2022: $40.8M$40.8M2022−23%
Operating income452-$101.8M in 2022+147% since 2020
-$150.0M-$100.0M-$50.0M02020: -$41.1M-$41.1M20202021: -$81.3M-$81.3M2021+98%2022: -$101.8M-$101.8M2022+25%
Net income452-$117.5M in 2022−75% since 2020
-$600.0M-$400.0M-$200.0M02020: -$470.4M-$470.4M20202021: -$78.9M-$78.9M2021−83%2022: -$117.5M-$117.5M2022+49%
Fiscal year20182019202020212022
Revenue$65.1M4$83.5M5$94.3M2
Cost of revenue$30.4M5$53.5M2
Gross profit$39.9M4$53.0M5$40.8M2
Research and development$39.9M5$42.1M2
Operating income-$41.1M4-$81.3M5-$101.8M2
Interest$824.0K5$16.2M2
Income before tax-$78.9M5-$117.5M2
Income tax0 CNY20 CNY2
Net income-$470.4M4-$78.9M5-$117.5M2
Earnings per share-4 CNY/shares4-5 CNY/shares5-10 CNY/shares2-1 CNY/shares2-2 CNY/shares2
Shares (weighted, basic)460.5M shares2464.0M shares2

Compare Genetron Holdings Ltd with another company

Corporate structure

Genetron Holdings Ltd sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Genetron Holdings Ltd

  • Genetron Holdings Ltd Beijing, China

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Genetron Holdings Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$20.1M2 Dec 31, 2022$17.3M5 Dec 31, 2021+16.2%
Operating-lease assets (leased space)$5.6M2 Dec 31, 2022$8.2M5 Dec 31, 2021−31.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$25.6M2 Dec 31, 2022$92.7M2 Dec 31, 2021−72.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$4.6M2 Dec 31, 2022$3.2M5 Dec 31, 2021+43.2%

Inventory

ItemLatestA year beforeChange
Inventory, total$6.2M2 Dec 31, 2022$5.6M5 Dec 31, 2021+10.1%

Filings

51 filings to the SEC since October 2021: 2 annual reports, 15 large holders, 34 other. The latest 20:

  1. Apr 8, 202415-12G EDGAR
  2. Apr 2, 2024SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D EDGAR
  3. Apr 1, 2024SC 13D/A EDGAR
  4. Mar 29, 2024SC 13D/A SCHEDULE 13D, AMENDMENT NO. 1 EDGAR
  5. Mar 29, 2024SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D EDGAR
  6. Mar 29, 2024S-8 POS EDGAR
  7. Mar 28, 2024SC 13E3/A EDGAR
  8. Mar 28, 20246-K EDGAR
  9. Feb 21, 20246-K EDGAR
  10. Jan 17, 2024SC 13E3/A EDGAR
  11. Jan 17, 20246-K EDGAR
  12. Jan 5, 2024CORRESP EDGAR
  13. Jan 5, 2024SC 13E3/A EDGAR
  14. Dec 21, 2023UPLOAD EDGAR
  15. Nov 27, 2023SC 13E3 EDGAR
  16. Oct 27, 20236-K EDGAR
  17. Oct 24, 2023SC 13D EDGAR
  18. Oct 23, 2023SC 13D EDGAR
  19. Oct 20, 2023SC 13D SCHEDULE 13D EDGAR
  20. Oct 20, 2023SC 13D EDGAR

The 51 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Genetron Holdings Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGenetron Holdings Ltd1
  • CIK0001782594
  • Filer statusAccelerated filer1
  • Incorporated inCayman Islands1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8071 Services-Medical Laboratories1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District, Beijing, F4 1022061
  • Phone86 (10) 5090 75001
  • Shares outstanding452,807,305 as of Dec 31, 20222
  • On EDGAR sinceSep 3, 20191
  • Filings92 in all: 6-K (26), CORRESP (10), UPLOAD (10), SC 13D (6), SC 13G (6), SC 13G/A (5), SC 13D/A (4), 20-F (3)1
    All 25 form types

    F-1/A (3), SC 13E3/A (3), DRSLTR (2), 15-12G (1), 25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), DRS/A (1), EFFECT (1), F-1 (1), FWP (1), NT 20-F (1), S-8 (1), S-8 POS (1), SC 13E3 (1)

  • Latest filingsAnnual report (20-F) May 12, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13